This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Edel, J. Articles by Sabbioni, E. Search for Related Content PubMed Articles by Edel, J. Articles by Sabbioni, E. Social Bookmarking                         What's this?

Pathways of Cr (III) and Cr (VI) in the Rat after Intratracheal Administration

Commission of the European Communities, Radiochemistry and Nuclear Chemistry Division, Joint Research Centre, Ispra Establishment, I-21020 Ispra (Varese), Italy

E. Sabbioni

Commission of the European Communities, Radiochemistry and Nuclear Chemistry Division, Joint Research Centre, Ispra Establishment, I-21020 Ispra (Varese), Italy

⁵¹Cr-labelled Cr³⁺ and CrO^2-₄ solutions were administered intratracheally to male rats in doses of 0.1 and 10 µg of Cr per rat to evidentiate metabolic differences especially in the lung and in the mechanisms of excretion. Twenty four hours after administration the highest ⁵¹ Cr amount was present in the lungs for both valency states, being in the Cr (III)-treated group, however, about two times higher. In all other tissues tested the values in the Cr (VI)-treated animals were much higher.

Intracellularly, in the Cr (III)-treated group more than 40% of the total lung homogenate was found in the nuclear fraction and only 10% in the cytosol. In the Cr (VI)-treated group 25% was present in the nuclei and more than 50% in the cytosol. Gel filtration 24 h after intratracheal injection showed that in both cytosols chromium was eluted in three peaks including a low-molecular-weight component. Quantitatively, however, the ratios between the ⁵¹Cr associated with the three peaks were significantly different between the Cr (III)- and the Cr (VI)-treated animals. This suggests that binding of chromium to low-molecular-weight components should be involved in the passage of this element from the lung to the other tissues.

Excretion studies for 7 days showed that after this time the Cr (III)-treated animals excreted about 4% of the dose via urine and more than 36% via faeces, whereas in the Cr (VI)-treated rats the ⁵¹Cr was eliminated nearly equally between urine and faeces.

Human & Experimental Toxicology, Vol. 4, No. 4, 409-416 (1985)
DOI: 10.1177/096032718500400407


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?